HOUSTON (AP) _ Bellicum Pharmacueticals Inc. (BLCM) on Tuesday reported a loss of $21.9 million in its fourth quarter.
On a per-share basis, the Houston-based company said it had a loss of 66 cents. Losses, adjusted to extinguish debt, were 61 cents per share.
The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 69 cents per share.
For the year, the company reported that its loss widened to $91.8 million, or $2.89 per share. Revenue was reported as $185,000.
Bellicum Pharmaceuticals shares have decreased roughly 4 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $8.08, a decrease of 43 percent in the last 12 months.